OKYO Pharma Limited (LON:OKYO – Get Free Report)’s share price traded down 24.3% during trading on Tuesday . The company traded as low as GBX 1.40 ($0.02) and last traded at GBX 1.40 ($0.02). 364,142 shares traded hands during mid-day trading, a decline of 16% from the average session volume of 431,999 shares. The stock had previously closed at GBX 1.85 ($0.02).
OKYO Pharma Stock Down 24.3 %
The company has a current ratio of 0.83, a quick ratio of 2.65 and a debt-to-equity ratio of 1.65. The stock has a 50 day simple moving average of GBX 1.40 and a 200 day simple moving average of GBX 1.40. The firm has a market capitalization of £23.24 million, a PE ratio of -140.00 and a beta of -0.06.
OKYO Pharma Company Profile
OKYO Pharma Limited, a preclinical biopharmaceutical company, engages in developing therapeutics for patients suffering from inflammatory eye diseases and ocular pain in the United Kingdom. Its lead product includes OK-101 for the treatment of dry eye disease. The company is also developing OK-201, a bovine adrenal medulla, lipidated-peptide preclinical analogue candidate for the treatment of neuropathic ocular pain.
Further Reading
- Five stocks we like better than OKYO Pharma
- What is a Dividend King?
- Silicon Motion Proves That AI in Motion Stays in Motion
- Do Real Estate Investment Trusts Deserve a Place in Your Portfolio?
- Undervalued UnitedHealth Group Won’t Be For Long
- 5 Top Rated Dividend Stocks to Consider
- The 5 Stocks Most Sold By Insiders This Year
Receive News & Ratings for OKYO Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for OKYO Pharma and related companies with MarketBeat.com's FREE daily email newsletter.
